Karyopharm Therapeutics (25K.F) Q3 2024 Earnings

Aug 6Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.31
-0.27
-0.23
-0.18

Details

Expected EPS
-0.27261659782
Actual EPS
-0.183052
Surprise EPS
0.09
Surprise Percent
+32.85%

Description

⁨Karyopharm Therapeutics⁩ (⁦25K.F⁩) has reported earnings of ⁦-0.183052⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts